Identification of a new HLA-B*44 allele, HLA-B*44:02:68, by next generation sequencing.


Journal

HLA
ISSN: 2059-2310
Titre abrégé: HLA
Pays: England
ID NLM: 101675570

Informations de publication

Date de publication:
08 2021
Historique:
revised: 25 01 2021
received: 12 01 2021
accepted: 27 01 2021
pubmed: 3 2 2021
medline: 12 8 2021
entrez: 2 2 2021
Statut: ppublish

Résumé

HLA-B*44:02:68 differs from B*44:02:01:01 by one synonmous nucleotide substitution in codon-10 GGG- > GGA.

Identifiants

pubmed: 33527766
doi: 10.1111/tan.14196
doi:

Substances chimiques

Codon 0
HLA-B Antigens 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

162-163

Informations de copyright

© 2021 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Références

Robinson J, Barker DJ, Georgiou X, Cooper MA, Flicek P, Marsh SGE. IPD-IMGT/HLA database. Nucleic Acids Res. 2020;48:D948-D955.
Marsh SGE, Albert ED, Bodmer WF, et al. Nomenclature for factors of the HLA system. Tissue Antigens. 2010;75:291-455.

Auteurs

Maria Troiano (M)

Laboratory of Immunogenetics and Transplant, Department of Oncohematology and cell and Gene Terapy, IRCCS Bambino Gesù Pediatric Hospital, Rome, Italy.

Franco Locatelli (F)

Department of Pediatrics, Sapienza, University of Rome, Rome, Italy.

Paola Giustiniani (P)

Laboratory of Immunogenetics and Transplant, Department of Oncohematology and cell and Gene Terapy, IRCCS Bambino Gesù Pediatric Hospital, Rome, Italy.

Antonio G Bianculli (AG)

Laboratory of Immunogenetics and Transplant, Department of Oncohematology and cell and Gene Terapy, IRCCS Bambino Gesù Pediatric Hospital, Rome, Italy.

Marco Andreani (M)

Laboratory of Immunogenetics and Transplant, Department of Oncohematology and cell and Gene Terapy, IRCCS Bambino Gesù Pediatric Hospital, Rome, Italy.

Articles similaires

Genome, Chloroplast Phylogeny Genetic Markers Base Composition High-Throughput Nucleotide Sequencing

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C

Classifications MeSH